Synthetic calanolides with bactericidal activity against replicating and nonreplicating mycobacterium tuberculosis

Journal of Medicinal Chemistry

Volumn 57, Issue 9, 2014, Pages 3755-3772

  Zheng, Purong ^a   Somersan Karakaya, Selin ^b   Lu, Shichao ^a   Roberts, Julia ^b   Pingle, Maneesh ^b   Warrier, Thulasi ^b   Little, David ^b   Guo, Xiaoyong ^a   Brickner, Steven J ^c   Nathan, Carl F ^b   Gold, Ben ^b   Liu, Gang ^a  

^a Tsinghua University   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c SJ Brickner Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPHENYL; CALANOLIDE A; HEXACHLOROPHENE; LEAD;

ARTICLE; BACTERICIDAL ACTIVITY; DRUG SYNTHESIS; GENOTOXICITY; IN VITRO STUDY; MACROPHAGE; MAMMAL CELL; MYCOBACTERIUM TUBERCULOSIS; YEAST;

ANTITUBERCULAR AGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRANOCOUMARINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84900333791     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4019228     Document Type: Article

References (44)

1. World Health Organization. Global tuberculosis control: WHO report 2010. WHO Press: Geneva, Switzerland, 2010.
2. Gandhi, N. R.; Nunn, P.; Dheda, K.; Schaaf, H. S.; Zignol, M.; van Soolingen, D.; Jensen, P.; Bayona, J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis Lancet 2010, 375, 1830-1843
3. Koul, A.; Arnoult, E.; Lounis, N.; Guillemont, J.; Andries, K. The challenge of new drug discovery for tuberculosis Nature 2011, 469, 483-490
4. Ma, Z.; Lienhardt, C.; McIlleron, H.; Nunn, A. J.; Wang, X. Global tuberculosis drug development pipeline: the need and the reality Lancet 2010, 375, 2100-2109
5. Gutierrez-Lugo, M.; Bewley, C. A. Natural products, small molecules, and genetics in tuberculosis drug development J. Med. Chem. 2008, 51, 2606-2612
6. Frothingham, R.; Stout, J. E.; Hamilton, C. D. Current issues in global tuberculosis control Int. J. Infect. Dis. 2005, 9, 297-311
7. Xie, Z.; Siddiqi, N.; Rubin, E. J. Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates Antimicrob. Agents Chemother. 2005, 49, 4778-4780
8. Nathan, C. Fresh approaches to anti-infective therapies Sci. Transl. Med. 2012, 4, 140sr2
9. Nathan, C.; Gold, B.; Lin, G.; Stegman, M.; de Carvalho, L. P.; Vandal, O.; Venugopal, A.; Bryk, R. A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis Tuberculosis 2008, 88, S25-S33
10. Bryk, R.; Gold, B.; Venugopal, A.; Singh, J.; Samy, R.; Pupek, K.; Cao, H.; Popescu, C.; Gurney, M.; Hotha, S.; Cherian, J.; Rhee, K.; Ly, L.; Converse, P. J.; Ehrt, S.; Vandal, O.; Jiang, X.; Schneider, J.; Lin, G.; Nathan, C. Selective killing of nonreplicating Mycobacteria Cell Host Microbe 2008, 3, 137-145
11. Gold, B.; Pingle, M.; Brickner, S. J.; Shah, N.; Roberts, J.; Rundell, M.; Bracken, W. C.; Warrier, T.; Somersan, S.; Venugopal, A.; Darby, C.; Jiang, X.; Warren, J. D.; Fernandez, J.; Ouerfelli, O.; Nuermberger, E. L.; Cunningham-Bussel, A.; Rath, P.; Chidawanyika, T.; Deng, H.; Realubit, R.; Glickman, J. F.; Nathan, C. Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 16004-16011
12. Mak, P. A.; Rao, S. P.; Ping Tan, M.; Lin, X.; Chyba, J.; Tay, J.; Ng, S. H.; Tan, B. H.; Cherian, J.; Duraiswamy, J.; Bifani, P.; Lim, V.; Lee, B. H.; Ling Ma, N.; Beer, D.; Thayalan, P.; Kuhen, K.; Chatterjee, A.; Supek, F.; Glynne, R.; Zheng, J.; Boshoff, H. I.; Barry, C. E., 3rd; Dick, T.; Pethe, K.; Camacho, L. R. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis ACS Chem. Biol. 2012, 7, 1190-1197
13. Kashman, Y.; Gustafson, K. R.; Fuller, R. W.; Cardellina, J. H., II; McMahon, J. B.; Currens, M. J.; Buckheit, R. W., Jr; Hughes, S. H.; Cragg, G. M.; Boyd, M. R. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, calophyllum lanigerum J. Med. Chem. 1992, 35, 2735-2743
14. Eiznhamer, D. A.; Creagh, T.; Ruckle, J. L.; Tolbert, D. T.; Giltner, J.; Dutta, B.; Flavin, M. T.; Jenta, T.; Xu, Z. Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers HIV Clin. Trials 2002, 3, 435-450
15. Xu, Z. Q.; Barrow, W. W.; Suling, W. J.; Westbrook, L.; Barrow, E.; Lin, Y. M.; Flavin, M. T. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis Bioorg. Med. Chem. 2004, 12, 1199-1207
16. Xu, Z. Q.; Pupek, K.; Suling, W. J.; Enache, L.; Flavin, M. T. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis Bioorg. Med. Chem. 2006, 14, 4610-4626
17. Chenera, B.; West, M. L.; Finkelstein, J. A.; Dreyer, G. B. Total synthesis of (+)-calanolide A, a non-nucleoside inhibitor of HIV-1 reverse transcriptase J. Org. Chem. 1993, 58, 5605-5606
18. Deshpande, P. P.; Tagliaferri, F.; Victory, S. F.; Yan, S.; Baker, D. C. Synthesis of optically active calanolides A and B J. Org. Chem. 1995, 60, 2964-2965
19. Trost, B. M.; Toste, F. D. A catalytic enantioselective approach to chromans and chromanols. A total synthesis of (-)-calanolide A and B and the vitamin E nucleus J. Am. Chem. Soc. 1998, 120, 9074-9075
20. Sekino, E.; Kumamoto, T.; Tanaka, T.; Ikeda, T.; Ishikawa, T. Concise synthesis of anti-HIV-1 active (+)-inophyllum B and (+)-calanolide A by application of (-)-quinine-catalyzed intramolecular oxo-Michael addition J. Org. Chem. 2004, 69, 2760-2767
21. Khilevich, A.; Mar, A.; Flavin, M. T.; Rizzo, J. D.; Dzekhtser, S.; Brankovic, D.; Lin, L.; Zhang, H.; Chen, W.; Liao, S.; Zembower, D. E.; Xu, Z. Q. Synthesis of (+)-calanolide A, an anti-HIV agent, via enzyme-catalyzed resolution of the Aldol products Tetrahedron: Asymmetry 1996, 7, 3315-3326
22. Ma, T.; Liu, L.; Xue, H.; Li, L.; Han, C.; Wang, L.; Chen, Z.; Liu, G. The chemical library and structure-activity relationship of 11-demethyl-12-oxo calanolide A analogues against HIV-1 J. Med. Chem. 2008, 51, 1432-1446
23. Xue, H.; Lu, X.; Zheng, P.; Liu, L.; Han, C.; Hu, J.; Liu, Z.; Ma, T.; Li, Y.; Wang, L.; Chen, Z.; Liu, G. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile J. Med. Chem. 2010, 53, 1397-1401
24. Lu, X.; Liu, L.; Zhang, X.; Lau, T. C.; Tsui, S. K.; Kang, Y.; Zheng, P.; Zheng, B.; Liu, G.; Chen, Z. F18, a novel small molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis Antimicrob. Agents Chemother. 2012, 56, 341-351
25. Zhang, J.; Kirchhoff, E. W.; Zembower, D. E.; Jimenez, N.; Sen, P.; Xu, Z. Q.; Flavin, M. T. Automated process research: an example of accelerated optimization of the Friedel-Crafts acylation reaction, a key step for the synthesis of anti-HIV (+)-calanolide A Org. Process Res. Dev. 2000, 4, 577-580
26. Deshpande, P. P.; Tagliaferri, F.; Victory, S. F.; Yan, S.; Baker, D. C. Synthesis of optically active calanolide A and B J. Org. Chem. 1995, 60, 2964-2965
27. Fox, M. E.; Lennon, I. C.; Meek, G. A novel synthesis of 5-hydroxy-2,2-dimethyl-10-propyl-2 H -pyrano[2,3- f ]chromen-8-one Tetrahedron Lett. 2002, 43, 2899-2902
28. Fan, R.; Sun, Y.; Ye, Y. Iodine(III)-mediated tandem acetoxylation- cyclization of o -acyl phenols for the facile construction of ?-acetoxybenzofuranones Org. Lett. 2009, 11, 5174-5177
29. Zheng, P.; Lu, S.; Liu, G. An unexpected C-C cleavage reaction: new and mild access to o -OH and o -NH-Ts benzoic acids or benzoamides Mol. Diversity 2011, 15, 971-977
30. Vass, M.; Hruska, K.; Franek, M. Nitrofuran antibiotics: a review on the application, prohibition and residual analysis Vet. Med. 2008, 53, 469-500
31. Genevieve, L.; Pierre, D.; Rene, R.; Philippe, G.; Jacky, F. Synthesis and microorganism-inhibiting effects of 3-methoxy-2-nitrobenzofuran having a monomethoxy group on the benzene ring Eur. J. Med. Chem. (Chimie therapeutique) 1986, 21, 379-383
32. Zhou, L.; Ishizaki, H.; Spitzer, M.; Taylor, K. L.; Temperley, N. D.; Johnson, S. L.; Brear, P.; Gautier, P.; Zeng, Z.; Mitchell, A.; Narayan, V.; McNeil, E. M.; Melton, D. W.; Smith, T. K.; Tyers, M.; Westwood, N. J.; Patton, E. E. ALDH2 mediates 5-nitrofuran activity in multiple species Chem. Biol. 2012, 19, 883-892
33. Debnath, A. K.; Lopez de Compadre, R. L.; Debnath, G.; Shusterman, A. J.; Hansch, C. Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity J. Med. Chem. 1991, 34, 786-797
34. Royer, R. R.; Demerseman, P. G.; Rene, L. J.; Cavier, R. E. 2-Nitro-5 or 6 or 7-methoxy benzofuran. U.S. Patent No. 3,838,173 A, 1974.
35. Plantan, I.; Selic, L.; Mesar, T.; Anderluh, P. S.; Oblak, M.; Prezelj, A.; Hesse, L.; Andrejasic, M.; Vilar, M.; Turk, D.; Kocijan, A.; Prevec, T.; Vilfan, G.; Darko, K.; Copar, A.; Urleb, U.; Solmajer, T. 4-Substituted trinems as broad spectrum β-lactamase inhibitors: structure-based design, synthesis, and biological activity J. Med. Chem. 2007, 50, 4113-4121
36. Butts, C. P.; Eberson, L.; Gonzals-Luque, R.; Hartshorn, C. M.; Hartshorn, M. P.; Merchan, M.; Robinson, W. T.; Roos, B. O.; Vallance, C.; Wood, B. R. Photochemical nitration by tetranitromethane. Part XL. Regiochemistry of trinitromethyl attachment in the photolysis of benzofuran with tetranitromethane Acta Chem. Scand. 1997, 51, 984-999
37. Chang, C. W.; Chein, R. J. Absolute configuration of anti-HIV-1 agent (-)-Concentricolide: total synthesis of (+)-(R)-Concentricolide J. Org. Chem. 2011, 76, 4154-4157
38. Koyanagi, J.; Yamamoto, K.; Nakayama, K.; Tanaka, A. A new synthetic route to 2-substituted naphtho[2,3-b]furan-4,9-dione J. Heterocycl. Chem. 1997, 34, 407-412
39. Padwa, A.; Dimitroff, M.; Waterson, A. G.; Wu, T. Diels-Alder reaction of 2-amino-substituted furans as a method for preparing substituted anilines J. Org. Chem. 1997, 62, 4088-4096
40. Lu, S.; Zheng, P.; Liu, G. Iodine(III)-mediated tandem oxidative cyclization for construction of 2-nitrobenzo[b]furans J. Org. Chem. 2012, 77, 7711-7717
41. Hisato, T.; Shoji, E. Synthesis of novel carbo- and heteropolycycles. Part 9. Benzylic azide functionalization of tautomeric o-acylbenzoic acid, -benzamide, and -nicotinic acid derivatives, and thermal decomposition of the derived azides J. Chem. Soc., Perkin Trans. 1 (1972-1999) 1988, 8, 2149-2154
42. Pelkey, E. T.; Gribble, G. W. Synthesis of 2-nitroindoles via the Sundberg indole synthesis Tetrahedron Lett. 1997, 38, 5603-5606
43. Glickman, M. S.; Jacobs, W. R., Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline Cell 2001, 104, 477-485
44. Vogt, G.; Nathan, C. In vitro differentiation of human macrophages with enhanced antimycobacterial activity J. Clin. Invest. 2011, 121, 3889-3901